Vyvanse (lisdexamfetamine) has two half-lives to consider: the prodrug itself clears your plasma in less than one hour, but the active component, dextroamphetamine, has a half-life of roughly 10 to 12 hours. That second number is the one that matters for how long the medication actually works and how long it stays in your system.
Why Vyvanse Has Two Half-Lives
Vyvanse is a prodrug, meaning it’s pharmacologically inactive when you swallow it. The capsule or chewable tablet delivers lisdexamfetamine, which is dextroamphetamine bonded to an amino acid called lysine. Your body has to strip that lysine off before the drug does anything useful. This conversion happens primarily on the surface of red blood cells, where enzymes break the bond and release dextroamphetamine into your bloodstream.
The prodrug form, lisdexamfetamine, peaks in the blood about one hour after you take it and is eliminated with a half-life averaging less than one hour. It disappears quickly because it’s being converted, not because it’s being excreted. The dextroamphetamine that results from that conversion peaks later, around 3.5 to 4.4 hours after you take the dose, and then clears much more slowly.
The Half-Life That Actually Matters
Dextroamphetamine is the molecule responsible for Vyvanse’s therapeutic effects. According to FDA prescribing information, its elimination half-life is approximately 8.6 to 9.5 hours in children ages 6 to 12, and 10 to 11.3 hours in healthy adults. Some sources round this to about 12 hours, which sits at the upper end of the range.
In practical terms, a half-life of 10 to 12 hours means that roughly half the active drug remains in your body about 10 to 12 hours after you take it. After another 10 to 12 hours, a quarter remains. It generally takes four to five half-lives for a drug to be considered fully eliminated, which puts the total clearance window at roughly two to three days after your last dose.
How Long the Effects Last
Half-life and duration of effect aren’t the same thing. You stop feeling a medication’s effects well before the drug is completely gone from your system. Clinical trials measured Vyvanse’s functional duration by testing performance at timed intervals throughout the day. In children ages 6 to 12, significant improvements in behavior were observed across a 12-hour assessment window. In adults, a workplace simulation study found measurable benefits at every time point tested, from 2 hours to 14 hours after the dose.
Most people experience roughly 10 to 14 hours of symptom coverage from a single dose. The gradual conversion from prodrug to active drug is what gives Vyvanse its smooth, extended profile compared to immediate-release stimulants, which hit harder and fade faster.
Factors That Change How Long It Lasts
The half-life of dextroamphetamine varies considerably based on urinary pH. When urine is more acidic (pH below 6.6), more than two-thirds of the drug is excreted unchanged through the kidneys, which speeds up clearance. When urine is more alkaline (pH above 6.7), less than half is excreted that way, so the drug lingers longer. This means things that acidify your urine, like high-dose vitamin C or cranberry juice, can shorten the drug’s effective duration, while alkaline conditions can extend it.
Age also plays a role. Children tend to clear dextroamphetamine somewhat faster than adults, with half-lives closer to 9 hours versus 10 to 11 hours. Body composition, kidney function, and individual metabolic variation all contribute to the range, which is why two people on the same dose can have noticeably different experiences with timing.
Prodrug Design and Abuse Deterrence
The reason Vyvanse was designed as a prodrug is partly about consistency and partly about reducing misuse potential. Because the drug must pass through an enzymatic conversion step on red blood cells before becoming active, there’s a built-in rate limit on how quickly dextroamphetamine enters the bloodstream. Crushing, snorting, or injecting the prodrug doesn’t bypass this step, so it’s difficult to get the rapid spike in blood levels that makes a stimulant feel euphoric.
This same mechanism is why Vyvanse tends to feel smoother than immediate-release dextroamphetamine. The conversion process acts like a time-release valve. Rather than a sharp peak followed by a quick drop, the active drug builds gradually, crests around 3.5 to 4.4 hours in, and tapers over the rest of the day.